EUVIMEDEUVIMED entdecken
Crossref

Prognostic Value of Myocardial Perfusion Scintigraphy with IQ∙SPECT Technology in Patients with Suspected or Known Coronary Artery Disease

Maria Fernanda Rezende, Davi Shunji Yahiro, Fernando de Amorim Fernandes, Jader Azevedo, Claudio Tinoco Mesquita

International Journal of Cardiovascular Sciences · 10.04.2026 · 39

DOI: 10.36660/ijcs.20240202 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Cardiovascular Sciences, erschienen am 10.04.2026. Verfasst von Maria Fernanda Rezende und 4 weiteren Autor:innen. Die Arbeit nennt 43 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

IQ∙SPECT is a collimator design coupled with a cardio-centric acquisition orbit and specific reconstruction algorithm that increases camera efficiency. However, there is no prognostic data derived from IQ∙SPECT exams.

Objectives

To evaluate the prognostic value of IQ∙SPECT myocardial perfusion scintigraphy (MPS) in patients with suspected or known coronary artery disease (CAD).

Methods

The study population consisted of 734 consecutive patients with suspected or known CAD submitted to MPS with IQ∙SPECT. Adequate follow-up was obtained in 625 patients. We retrospectively analyzed imaging and clinical data. The follow-up was obtained for no less than 12 months after the MPS study. Statistical significance was taken at p < 0.05.

Results

Normal IQ∙SPECT compared to abnormal IQ∙SPECT had lower annualized incidence of hard events (0.2% and 1.1%, respectively, p = 0.02), late combined events (1.1% and 5.5%, respectively, p = 0.008), and revascularization (1% and 14%, respectively, p < 0.001). Left ventricular ejection fraction ≤ 45% was found to be the only clinical predictor of hard events (p < 0.0003, confidence interval [CI] = 5.25 to 129.02). However, for combined events, abnormal MPS (p < 0.0001, CI = 3.39 to 11.13, hazard ratio [HR] = 6.14) and dyspnea/fatigue (p = 0.013, CI = 1.28 to 8.4, HR = 3.3) obtained statistical significance. In contrast, ischemic burden ≥ 5% (p < 0.0001, HR = 30.3) was the most relevant parameter for revascularization, followed by thoracic pain (p = 0.002, HR = 2.4).

Conclusion

Our study demonstrates that IQ SPECT MPS has significant prognostic capabilities with very low risk of adverse events in patients with normal findings.

Zitieren

APA

Rezende, M. F., Yahiro, D. S., Fernandes, F. D. A., Azevedo, J., & Mesquita, C. T. (2026). Prognostic Value of Myocardial Perfusion Scintigraphy with IQ∙SPECT Technology in Patients with Suspected or Known Coronary Artery Disease. International Journal of Cardiovascular Sciences, 39. https://doi.org/10.36660/ijcs.20240202

Vancouver

Rezende MF, Yahiro DS, Fernandes FDA, Azevedo J, Mesquita CT. Prognostic Value of Myocardial Perfusion Scintigraphy with IQ∙SPECT Technology in Patients with Suspected or Known Coronary Artery Disease. International Journal of Cardiovascular Sciences. 2026;39. doi:10.36660/ijcs.20240202

BibTeX
@article{Rezende2026,
  author = {Rezende, Maria Fernanda and Yahiro, Davi Shunji and Fernandes, Fernando de Amorim and Azevedo, Jader and Mesquita, Claudio Tinoco},
  title = {Prognostic Value of Myocardial Perfusion Scintigraphy with IQ∙SPECT Technology in Patients with Suspected or Known Coronary Artery Disease},
  journal = {International Journal of Cardiovascular Sciences},
  year = {2026},
  volume = {39},
  doi = {10.36660/ijcs.20240202}
}
Kostenlos starten →